Hsp104

Hsp104
Name	Hsp104
Organism	Saccharomyces cerevisiae
Length	~900 aa
Family	AAA+ ATPase

Hsp104 Hsp104 is a hexameric AAA+ ATPase chaperone from Saccharomyces cerevisiae notable for disaggregating protein aggregates and remodeling amyloid-like assemblies. It functions in cooperation with chaperone systems from Escherichia coli to Homo sapiens and has been studied across model organisms including Caenorhabditis elegans and Drosophila melanogaster. Hsp104 has been implicated in cellular protection during stresses studied by laboratories at institutions such as Cold Spring Harbor Laboratory, Max Planck Society, and Howard Hughes Medical Institute.

Introduction

Hsp104 was first characterized in studies of heat shock responses alongside factors studied by Lindquist Laboratory and researchers such as Susan Lindquist and M. Nomura. It is central to the protein quality control networks mapped in proteostasis research at centers like Institute of Protein Research and featured in reviews from journals published by Nature Publishing Group, Cell Press, and Proceedings of the National Academy of Sciences. Hsp104 activity interlocks with chaperones such as Hsp70, Hsp40, and co-chaperones studied by groups at National Institutes of Health and European Molecular Biology Laboratory.

Structure and Mechanism

Hsp104 assembles as a hexameric ring typical of AAA+ family enzymes characterized structurally by cryo-electron microscopy efforts at European Synchrotron Radiation Facility and single-particle analysis by teams at MRC Laboratory of Molecular Biology. Its domain architecture includes nucleotide-binding domains resembling motifs discovered in studies of ClpB from Bacillus subtilis and AAA+ proteins such as p97/VCP and ClpA. ATP binding and hydrolysis cycles coordinate substrate translocation through a central pore, a mechanism elucidated using techniques from X-ray crystallography at facilities like Stanford Synchrotron Radiation Lightsource and cryo-EM work by groups at Max Planck Institute for Biophysical Chemistry. Key residues were mapped in mutational screens performed by labs affiliated with University of California, San Francisco, Massachusetts Institute of Technology, and University of Cambridge.

Biological Functions and Cellular Roles

Hsp104 resolves stress-induced aggregates in pathways overlapping with those characterized in studies of ubiquitin systems from investigators at Cold Spring Harbor Laboratory and proteasome research groups at Princeton University. It cooperates with cytosolic and mitochondrial chaperones examined in contexts including models of temperature tolerance in Saccharomyces cerevisiae strains studied at John Innes Centre. Hsp104 influences prion propagation in yeast prion studies involving PSI+ and URE3 phenotypes reported by researchers at National Institute of Genetics and discussed in symposia hosted by Gordon Research Conferences. Its disaggregase action affects pathways intersecting with research on alpha-synuclein and amyloid-beta in laboratories at Massachusetts General Hospital and Columbia University.

Regulation and Expression

Hsp104 expression is induced by heat shock via transcriptional programs regulated by factors such as Heat shock factor 1 in yeast studies paralleling work on stress transcription factors investigated at Yale University and University of Toronto. Promoter analyses used reporter constructs in work from Stanford University and chromatin studies by teams at Harvard Medical School. Post-translational control involving phosphorylation and interactions with co-chaperones was explored in proteomics projects at European Bioinformatics Institute and mass spectrometry centers at Max Planck Institute for Biochemistry.

Clinical and Biotechnological Applications

Hsp104 and engineered variants have been tested for therapeutic potential in models of neurodegenerative disorders studied at University College London and University of California, San Diego, targeting misfolded proteins implicated in Parkinson's disease, Alzheimer's disease, and Huntington's disease. Protein engineering efforts drawing on directed evolution approaches at University of California, Berkeley and École Polytechnique Fédérale de Lausanne created variants with altered substrate specificity. Biotechnological applications include improving stress tolerance in industrial strains used by companies like Novozymes and in synthetic biology projects at Broad Institute and Biotechnology and Biological Sciences Research Council-funded consortia. Safety and translational challenges are discussed in reports from Food and Drug Administration forums and in collaborations with Bill & Melinda Gates Foundation-funded initiatives.

Evolutionary Conservation and Homologs

Homologs of Hsp104 occur across kingdoms, including bacterial ClpB in Escherichia coli and mitochondrial variants in Homo sapiens and plants studied at Wageningen University & Research. Comparative genomics performed by teams at European Molecular Biology Laboratory and National Center for Biotechnology Information reveal conservation of AAA+ motifs also found in proteins such as VCP and ClpX. Phylogenetic analyses from research groups at University of Oxford, University of Tokyo, and University of Melbourne place Hsp104 within a clade of disaggregases with lineage-specific diversification studied in parasitology contexts involving Plasmodium falciparum and bacterial stress responses investigated at Helmholtz Centre for Infection Research.

Category:Chaperone proteins